In patients with Type 2 diabetes, GLP-1 concentrations are decreased in response to an oral glucose load
Reconstitution B: 5 mg/5 mg vial + 3 mL BAC water (1,667 mcg/mL each) more BAC water for larger, easier-to-measure draws
In pig models of intestinal injury, oral BPC-157 reduced inflammatory markers and sealed epithelial gaps within days , translating into fewer symptoms like bloating, gas, and food sensitivities
Biochemical and biophysical research communications , 280 (1), 132138
Extracellular fluid volume expansion uncovers a natriuretic action of GLP-1: a functional GLP-1renal axis in man
Pfizer said it tested four formulations of the drug to determine which might be most effective, but didnt disclose which worked best, just saying one showed the most favorable profile. Candidly, todays trial never answered the question on what once-daily modified release dose would get to competitive efficacy, Raffat said in a note to investors